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Although the multiplication of bacteriophages (phages) has a substantial impact on the biosphere, comparatively little is
known about how the external environment affects phage production. Here we report that sub-lethal concentrations of certain
antibiotics can substantially stimulate the host bacterial cell’s production of some virulent phage. For example, a low dosage of
cefotaxime, a cephalosporin, increased an uropathogenic Escherichia coli strain’s production of the phage wMFP by more than
7-fold. We name this phenomenon Phage-Antibiotic Synergy (PAS). A related effect was observed in diverse host-phage
systems, including the T4-like phages, with b-lactam and quinolone antibiotics, as well as mitomycin C. A common
characteristic of these antibiotics is that they inhibit bacterial cell division and trigger the SOS system. We therefore examined
the PAS effect within the context of the bacterial SOS and filamentation responses. We found that the PAS effect appears SOS-
independent and is primarily a consequence of cellular filamentation; it is mimicked by cells that constitutively filament. The
fact that completely unrelated phages manifest this phenomenon suggests that it confers an important and general advantage
to the phages.
Citation: Comeau AM, Te ´tart F, Trojet SN, Pre `re M-F, Krisch HM (2007) Phage-Antibiotic Synergy (PAS): b-Lactam and Quinolone Antibiotics Stimulate
Virulent Phage Growth. PLoS ONE 2(8): e799. doi:10.1371/journal.pone.0000799
INTRODUCTION
The phage-infected bacterial cell undergoes a complex develop-
mental program that is largely defined by the phage genome.
Although this developmental cycle is generally well understood for
phages such as T4 or l [1,2], little is known about how the
external environment influences it. What is well known, however,
is that many classes of antibiotics inhibit bacterial cell division
[3,4] and can thus, at sub-lethal concentrations, increase the
biomass and hence the biosynthetic capacity of bacterial cells. A
fortuitous observation has allowed us to demonstrate that virulent
phages have evolved the capacity to take advantage of this altered
host cell state to increase their own production. A second
consequence of such drugs is to accelerate the lysis of the infected
cells, hence allowing the phages to spread more rapidly. We
discuss the observations that lead to the discovery of this
phenomenon, its characteristics, and the role that this phage-
antibiotic synergy could play in the natural environment.
RESULTS AND DISCUSSION
To determine the antibiotic sensitivity of the bacterium causing
a urinary tract infection in a hospitalized child, a Petri plate was
inoculated with a dilution of the patient’s urine and a series of
antibiotic disks were placed on the surface of the agar. As
suspected, the urine was contaminated with an uropathogenic
Escherichia coli strain, but also with phages that infected it.
Remarkably, with some of the antibiotics, the phage plaques were
significantly larger in zones circumscribing the disks where there
was a sub-lethal concentration of the drug. This effect was observed
with disks containing the b-lactam antibiotics (aztreonam, a mono-
bactam, and cefixime, a cephalosporin), but not with antibiotics of
other classes (tetracycline and gentamicin). Thus, a sub-lethal dosage
of b-lactam antibiotics appeared to stimulate phage growth in this
host-phage system. To further characterize this curious phenome-
non, both a single a colony of the uropathogenic E. coli isolate (MFP)
and a single phage plaque (wMFP) were isolated from the urine
sample. The synergistic effect was highly reproducible with these
purified isolates (Figure 1) and was not the result of induction of
lysogens (no appearance of phage on control plate)–we called this
effect PAS (Phage Antibiotic Synergy). Other cephalosporins
(cefotaxime, ceftriaxone, and ceftazidime) produced a similar effect
on wMFP growth in the E. coli MFP strain. Since this host strain is
resistant to many types of penicillins (e.g. piperacillin, ticarcillin and
amoxicillin), these drugs in the b-lactam family could not be tested.
Electron microscopy of the phage wMFP revealed morphology
typical of a siphovirus [5]: a long, flexible, non-contractile tail
structure and an isometric, icosahedral head of ,60 nm (data not
shown). DNA sequencing of 25 random ,500 bp segments of the
wMFP genome indicated that it is related to the Salmonella
typhimurium phage MB78 [6] (data not shown).
Since the PAS effect was only detectable in the zone adjacent to
the disk where the drug was not completely inhibiting bacterial
growth, we determined the drug concentration in Luria-Bertani
(LB) agar that gave the optimal PAS effect. These plates were
overlaid with soft LB agar containing the MFP indicator strain,
a fixed quantity of the wMFP phage and various concentrations of
the cephalosporin cefotaxime. Up to a concentration of 50 ng/
mL, the PAS response (as assayed by plaque diameter) increased
with the dose. As shown in Figure 2, this phage made quite small
plaques with no cefotaxime and remarkably large ones with the
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above 100 ng/mL inhibited the growth of the MFP bacterial strain
to a level that made the analysis phage plaque size impossible.
Plaque size is largely determined by two properties of the phage
infected cell: the phage burst size (the number of virions produced
by each infected cell) and the time it takes the phage to lyse an
infected cell. To determine if the cefotaxime-mediated increase in
plaque size was due directly to an increase in phage burst size, we
compared phage wMFP production when the MFP host cells were
grown in a liquid culture either with or without 20 ng/mL of
cefotaxime. The data in Figure 3 show that total phage production
in a single cycle of growth was greater in the presence of the
cephalosporin. This difference was detectable throughout the
latent period and was about 7-fold when the two cultures lysed.
However, the lysis of the antibiotic-treated infected culture was
also clearly affected, occurring more rapidly in the presence of the
drug (data not shown). It should be recalled that some mutant
phages lyse more rapidly and also make significantly larger plaques
than their wild type ancestor [7].
A search of the phage literature revealed that a possibly related
observation had been made in the classic T4 phage system. In
1969, Yamagami and Endo [8] observed that UV irradiation,
mitomycin C and a variety of other chemical treatments that cause
E. coli B to form filaments resulted in T4 plaques that were larger
than normal. To determine if the PAS phenomenon also occurred
in the T4-type phages, we identified two phages, RB32 and RB33
[9], in the Toulouse collection that grow well on E. coli MFP.
These phages have a contractile tail and are thus classified as
myoviruses [5], a phage family phylogenetically distinct from the
siphoviruses, such as wMFP. Both T4-type phages gave a clear
PAS response, in other words, much larger plaques when plated
on the host MFP in the presence of cefotaxime (Figure 4). A large
set of T4-like phages from the Toulouse collection were sub-
sequently tested on various standard laboratory E. coli strains and
most, but not all (e.g.: RB43), of these gave a positive PAS
response on host strains such as C600, P400, MC1061, S/6 and
AS19. The strain AS19, an antibiotic permeability mutant [10] of
E. coli B, was chosen for further studies of the PAS effect because
this host gave the most dramatic increase in plaque size for the
greatest number of T4-type phages tested. AS19 is very sensitive to
most b-lactam antibiotics, so additional drugs in this family could
be tested for PAS and many of these gave a positive PAS response
(data not shown). For example, the drugs ticarcillin, piperacillin,
ampicillin and, surprisingly, the structurally unrelated quinolone
nalidixic acid all increased T4 phage plaque size significantly.
Furthermore, the PAS response is not restricted to phage infections
in E. coli; we could demonstrate the phenomenon in an infection of
the phylogenetically distant host Yersinia pseudotuberculosis in an
infection with the T4-type Yersinia phage PST (data not shown).
The generality of the PAS phenomenon was further extended by
showing that phages T3 and T7, belonging to the phylogenetically
distant podoviruses [5] (the short-tailed family of phage), also gave
an impressive PAS response on the host AS19 (Figure 4).
To further examine the PAS effect in the T4-like phages, we
collected the soft agar containing AS19 host lawns from plates
containing a fixed, non-confluent, quantity of T4 plaques that had
been incubated the same amount of time either with or without
the antibiotic. The titers of these plate lysis stocks were then
compared. Phage T4 indeed showed an ,11-fold greater titer
when grown in the presence of 30 ng/mL of cefotaxime, and an
,9-fold increase in the presence of 200 ng/mL of mitomycin C.
To directly examine the kinetics of the T4 phage production, we
performed single burst experiments in liquid cultures of AS19 host
cells that were pre-treated with cefotaxime and then infected with
either T4 or two other T4-type phages, RB33 and RB49 [9]. In
such single cycle growth experiments, there was actually a slight
reduction in phage production, but this small effect was coupled to
a very significant reduction in the time to lyse the infected culture
(only 75–90 min compared to the normal 2 h). This result
provoked us to examine the effect of the antibiotics on T4 gene
t mutants which lack the holin gene that is primarily responsible
for the timing of host cell lysis [11]. Such phage mutants have
much delayed lysis, but the presence of the antibiotics largely
suppressed this phenotype (data not shown), consistent with the
drugs having a postulated effect of accelerating the time of lysis.
The PAS response appears to be explained by a simple
mechanism. There is a striking effect on cell morphology when
sensitive strains of E. coli grow in the presence of even very low
levels of b-lactam antibiotics. The mode of action of these
antibiotics is to block cell division [3] and, even with the sub-lethal
dosages that we employed, the cells divide poorly and form very
long filaments that eventually fatten somewhat. Furthermore, we
have verified by light microscopy that the cells filament in the
circular zone surrounding the antibiotic disks where the PAS
response occurs. Significantly, the chemically unrelated quinolone
antibiotic, nalidixic acid, which stimulates phage growth at levels
similar to the b-lactams also acts by inhibiting bacterial cell
division, but by a different mechanism [12]; as do mitomycin C
[13] and UV irradiation [14]. The SOS response in E. coli has long
been known to cause an inhibition of bacterial cell division in
response to DNA damage. Interestingly in the context of our
results, it has recently been demonstrated that the inactivation of
Figure 1. The PAS effect of phage wMFP on E. coli MFP on Luria-
Bertani agar plates. Only disks containing the b-lactam antibiotics
aztreonam and cefixime (indicated by ‘‘+’’ symbols) produced large
phage plaques in their proximity. Gentamicin and tetracycline gave no
PAS effect. This host strain was resistant to both amoxicillin and
trimethoprim/sulfamethoxazole. Note the absence of phages on the
left-hand control plate indicating the lack of prophage induction.
doi:10.1371/journal.pone.0000799.g001
Figure 2. Plaque sizes of phage wMFP on E. coli MFP with and
without 50 ng/mL of cefotaxime (CTX) in Luria agar plates.
doi:10.1371/journal.pone.0000799.g002
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lactam antibiotics also induces the expression of the SOS system
via a two-component signal transduction system [15]. Among the
numerous genes in the SOS regulon is the sulA (sfiA) gene that
encodes an inhibitor of cell division. Thus, the bacterial SOS
response to b-lactam antibiotics results in filamentation that allows
the bacteria to reduce the lethal effects of the drugs [15].
Obvious questions arise concerning a role of the bacterial SOS
response, and filamentation in general, in the PAS phenomenon.
To address these questions we employed a series of E. coli mutant
hosts, that were either defective in the SOS pathway or had an
altered filamentation response (constitutive filamentation), and
determined if they gave the PAS effect or not (Fig. 5). These results
indicate that the PAS effect is SOS pathway-independent as larger
plaques around the antibiotic halos were clearly present in the sulA
mutant, as well as in a lexA mutant which cannot de-repress the
SOS pathway genes (and hence should have no SOS response). A
recA mutant, defective for a major component of the SOS system,
showed a positive, but slightly dimished, PAS response (data not
shown). Thus, the SOS system does not seem to play a primary
role in the PAS response, it could nevertheless still play some
minor supporting role. However, the primarily SOS-independent
nature of the PAS effect may not be surprising given that
filamentation can still be induced by antibiotics in an SOS-
independent manner [16]. Turning to filamentation itself–if the
PAS effect is primarily due to the physiological changes in
filamenting cells, a mutant E. coli strain that is able to filament
without the activity of antibiotics should have a similar response.
That is exactly what is observed (Fig. 5) in an ftsZ mutant which
filaments due to its defective cell division apparatus. Phage plaques
on this mutant are uniformly bigger than the isogenic control
strain throughout the host lawn with only a very modest increase
in size near the zone of antibiotic activity.
The phenotype of filamentation therefore seems to play
a significant role in the PAS effect, probably through multiple
pathways. The altered physiological state of filamenting cells
obviously permits much faster phage assembly, possibly by making
larger/altered pools of precursors available and/or remedying
certain rate-limiting steps in assembly. We suggest that the
antibiotics also accelerate the timing of cell lysis given that
Figure 4. Plaque sizes of various coliphages with and without
cefotaxime (CTX) in Luria agar plates. Phages RB32 and RB33 were
grown on E. coli strain MFP (50 ng/mL CTX) at 37uC; and T4, T3 and T7
were grown on E. coli strain AS19 (30 ng/mL CTX) at 25uC. All plaques
were photographed at identical magnifications.
doi:10.1371/journal.pone.0000799.g004
Figure 5. The PAS effect of phage T4 on various E. coli SOS and
filamentation mutant strains. T4 was grown on E. coli sulA-inactivated
and lexA non-inducible mutant strains (defective SOS systems), as well
as an ftsZ-inactivated mutant strain (non-antibiotic induced filamenta-
tion), in the presence of disks of cefotaxime (CTX). Isogenic wild-type
strains (wt) are also included and representative plaques demonstrating
the PAS effect are indicated by red arrows. All plates were
photographed at identical magnifications.
doi:10.1371/journal.pone.0000799.g005
Figure 3. Increase in phage titer in the presence of the cephalosporin cefotaxime (CTX). E. coli strain MFP was infected with phage wMFP in Luria
liquid medium supplemented at the time of infection with 20 ng/mL of cefotaxime, or left untreated. The multiplicity of infection was ,5.
Chloroform was added at various times after infection to lyse the infected cells.
doi:10.1371/journal.pone.0000799.g003
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this probably causes a greater sensitivity to the action of phage lysis
genes (e.g. lysozymes, holins). The interplay of these two effects,
faster lysis and increased rate of phage production, cause the PAS
effect and it is not surprising that different phage-host systems,
with their different developmental programs and molecular
mechanisms of lysis, respond slightly differently. For example,
there is a significant increase in production in the siphophage
MFP-E. coli MFP system, whereas T4-infected E. coli AS19 does
not increase phage production, but does significantly reduce the
time of the infectious cycle in these T4-like phages. As
a consequence, the phages are produced more rapidly and hence
can diffuse further than normally, which causes an increase in
plaque size on solid media.
It is self-evident that the significant increases in phage
production reported here could be useful in certain biomedical
(e.g. phage therapy) or biotechnological applications. A more
fundamental question is whether the PAS response is simply
a useful curiosity, or a reflection of a previously unappreciated
aspect of the phage life-cycles, the ability to successfully adapt to
a ‘‘sub-optimal’’ environment for bacterial growth. The presence
in the environment of low levels of antibiotics that interfere with
cell wall synthesis represents a major threat to bacteria and it was
to be expected that they would develop strategies to minimize the
consequences of such agents. The SOS system induction of
filamentation can reduce the danger posed by such compounds
[15] and is thus evolutionarily advantageous. Phage of both the
temperate (induction of lysogens [17]) and virulent (PAS-enabled)
types have adapted to take advantage of the altered physiology of
such stressed cells and can propagate adventitiously in them,
producing more progeny than they would in ‘‘healthier’’
situations. This makes sense from an evolutionary perspective
since the host cells are likely to die anyway and getting a last, quick
burst of phage out of them before they do so is to the advantage of
the phage. From an ecological perspective, this seemingly bizarre
situation can be viewed as a mutualism between the fungal or
bacterial cells producing the antibiotics and PAS-enabled phages to
more efficiently compete with antibiotic- and phage-sensitive
bacterial cells. This synergistic interaction between phages and
antibiotic-producing cells could play a role in determining
population balances in the microfauna of biofilms, for example.
Clearly, more investigation will be required to assess the impact that
PAS has on the microbial ecosystem. With respect to the clinical
setting, there is perhaps a lesson to be learned here from nature–if
your objective is to kill bacteria, then giving them a tad of b-lactam
antibiotics combined with a dash of phage may be better at
accomplishing this task than either treatment individually.
MATERIALS AND METHODS
Phages and bacteria
All phages and bacteria were from the Toulouse Laboratory
collection of T4-like phages and their hosts, except for the
following: the phage-host system MFP was isolated from a urine
sample of an infected pediatrics patient using streak plating and
standard phage techniques [1]; phages T3 and T7 were kindly
provided by Ian Molineaux (University of Texas); E. coli SOS and
filamentation mutants were kindly provided by our LMGM
colleagues, Kaymeuang Cam, Franc ¸ois Cornet and David Lane.
The SOS mutants employed were sulA-inactivated (Coli Genetic
Stock Center [CGSC] strain AB1157 with sulA::Tn5), recA-
inactivated (CGSC strain AB2463) or lexA non-inducible (CGSC
strain AB2494) compared to the isogenic wild-type strain (CGSC
strain AB1157). The filamentation mutant employed was ftsZ-
inactivated (strain SK686=ftsZ84 in MG1655 Dlac) compared to
the isogenic wild-type strain (strain SK683=MG1655 Dlac).
Antibiotics and phage production assays
Antibiotic disks for solid assays were obtained from Bio-Rad;
powdered drugs for liquid assays and soft agar overlays were
obtained from Sigma and diluted to the desired concentrations in
sterile water. Liquid one-step growth curves, agar overlays and
solid plate stocks were performed as described previously [1], with
the addition of the appropriate antibiotic types/forms (disks or
solutions) to the appropriate media.
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